• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Show Search
Home
EN / FR
  • LinkedIn
  • Twitter
Celyad Oncology

Celyad Oncology

  • About Us
    • Overview
    • Management Team
    • Board Of Directors
    • Scientific Advisory Board
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • TIM
      • shRNA
    • Manufacturing
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Contact Us
    • Careers
Home / Investors / Corporate Governance

Corporate Governance

Corporate Governance

The Company has opted for a one-tier governance structure. The Board of Directors is the ultimate decision-making body of the Company, except with respect to those areas that are reserved by law or by the Company’s Articles of Association to the Shareholders’ Meeting. The corporate governance of the Company is structured pursuant to Belgian Code of the Companies and Associations (the “CCA”), the Company's articles of association, and the Company's corporate governance charter adopted in accordance with the Belgian Corporate Governance Code 2020.

Corporate Governance Charter
Charte de Gouvernance d'Entreprise
Dealing code
Code de transaction
Code of Business Conduct and Ethics
Code d'éthique et de conduite de la société
Coordinated Articles of Association
Articles Coordonnés de Associés
Texte coordoné des statuts

Board Of Directors

The Board of Directors currently consists of nine members. The directors have been appointed at the Shareholders Meeting of the Company. The Board’s composition reflects a diverse and complementary range of experience, nationalities and cultures, ensuring that the interests of all shareholders are taken into account. Members of the BoD are chosen for their skills, their integrity and their independence of mind.

Michel Lussier¹, Chairman, Non-executive director

Chris Buyse, Non-executive director

Serge Goblet, Non-executive director

Rudy Dekeyser², Non-executive director

Marina Udier, Independent director

Hilde Windels, Independent director

Filippo Petti, Executive director

Maria Koehler, Independent director

Dominic Piscitelli, Independent director

¹permanent representative of Mel Management SRL

²permanent representative of R.A.D. Lifesciences BVBA

Committees of the board of directors

The Board of Directors has set up committees to analyze and advise the Board of Directors on specific matters. Such committees are advisory bodies only and the decision-making remains the collegiate responsibility of the Board of Directors.

The Board of Directors has set-up a Nomination and Remuneration Committee composed of Michel Lussier (Chairman), Dominic Piscitelli, Hilde Windels and Filippo Petti (invited member).

The Board of Directors has set-up an Audit Committee composed of Dominic Piscitelli (Chairman), Chris Buyse and Hilde Windels.

Executive COMMITTEE

The Board of Directors has established an Executive Committee composed of the "Chief Executive officer" (CEO) and "Chief Financial Officer" (CFO), who is the chairman of the Executive Committee, the "Vice President Clinical Development & Medical Affaires", the "Chief Scientific Officer" (CSO), the "Chief Legal Officer" (CLO), the "Vice President Human Resources" and the "Chief Business Officer" (CBO). The Executive Committee discusses and consults with the Board of Directors on the day-to-day management of the Company in accordance with the Company's values, strategy, general policy and budget, as determined by the BoD.

Filippo Petti, Chief Executive Officer, CFO

Frédéric Lehmann3, VP Medical Affairs and Clinical Development

Stephen Rubino, Chief Business Officer

David Gilham, Chief Scientific Officer

Philippe Dechamps1, Chief Legal Officer

Philippe Nobels2, VP of Human Resources

 

1. Permanent representative of Nanda Devi SRL
2. Permanent representative of MC Consult SRL
3. Permanent representative of ImXsense SRL

 

Footer

  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.
Cookie Policy | Privacy Policy | Terms of Use

Our website uses cookies including analytics cookies to help improve it by collecting statistics on how visitors use our website. By clicking on "I accept", you allow us to place these analytics cookies. We also use cookies that are necessary for the good functioning of our website. You can find out more information about the cookies we use by visiting our Cookie Policy. I acceptI refuseCookie Policy